What happened
Union Korea Pharm updated the terms of a private placement (third-party allotment) to raise US$20.2M, about 15.6% of its market value.
For context, this raise equals about 15.6% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$20.2M |
| vs. market value | 15.6% |
| Filed | 2026-07-14, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260714000085 → open original filing |
Source: DART. Information only, not investment advice.